Table 8 Multivariate COX regression model for overall survival (A) and disease-free survival analysis (B) of MALAT1, LINC00943, and LINC00261

Number of cases, Total

Number of cases, Decased

Median Months, Overall

OR

95%CI

p-value

 with CNV deficiency

82

53

34.23

0.714

0.524–0.975

0.034

 without CNV deficiency

454

243

63.53

 with CNV deficiency

54

34

55.59

0.671

0.465–0.969

0.033

 without CNV deficiency

482

262

61.05

 with CNV deficiency

23

16

17.03

0.612

0.356–1.053

0.076

 without CNV deficiency

513

280

61.05

Number of cases, Total

Number of cases, Decased

Median Months, Overall

OR

95%CI

p-value

 with CNV deficiency

84

69

15.52

0.691

0.528–0.906

0.007

 without CNV deficiency

448

331

27.09

 with CNV deficiency

55

45

21.37

0.704

0.511–0.971

0.033

 without CNV deficiency

477

355

24.82

 with CNV deficiency

23

19

13.50

0.842

0.516–1.374

0.491

 without CNV deficiency

509

381

25.02